Researchers say studies of experimental cancer drugs are safer than ever, with the chance of dying in an early-stage test falling tenfold since 1991. The study, published in the Journal of the American Medical Association, tracked patients in studies from 1991 to 2002.
Researchers credited drugs that were less toxic and more highly targeted to specific problem areas than previous medicines. NPR's Richard Knox reports.
Copyright 2022 NPR. To see more, visit https://www.npr.org.
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.
